vs
ASSOCIATED BANC-CORP（ASB）与Ascendis Pharma A/S（ASND）财务数据对比。点击上方公司名可切换其他公司
ASSOCIATED BANC-CORP的季度营收约是Ascendis Pharma A/S的1.4倍（$383.0M vs $267.3M），过去两年Ascendis Pharma A/S的营收复合增速更高（60.7% vs 9.1%）
联合银行集团（Associated Banc-Corp）是美国区域性银行控股公司，总部位于威斯康星州格林贝，深耕美国中西部地区，主营零售银行、商业银行、商业地产贷款、私人银行及特色金融服务，在威斯康星州、伊利诺伊州、明尼苏达州设有220多个营业网点，覆盖100多个社区，还在印第安纳、密歇根等多州设有贷款办事处。
Ascendis Pharma A/S是一家聚焦内分泌疾病治疗领域的生物制药企业，核心业务覆盖生长激素疗法的研发、生产与商业化。其依托重组DNA技术生产的生长激素类处方药物，可用于治疗多种生长激素缺乏相关适应症，临床应用场景广泛。
ASB vs ASND — 直观对比
营收规模更大
ASB
是对方的1.4倍
$267.3M
两年增速更快
ASND
近两年复合增速
9.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $383.0M | $267.3M |
| 净利润 | $119.6M | — |
| 毛利率 | — | 90.5% |
| 营业利润率 | — | — |
| 净利率 | 31.2% | — |
| 营收同比 | — | 42.3% |
| 净利润同比 | 566.6% | — |
| 每股收益（稀释后） | $0.70 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASBASND
| Q1 26 | $383.0M | — | ||
| Q4 25 | $310.0M | $267.3M | ||
| Q3 25 | $305.2M | $230.7M | ||
| Q2 25 | $300.0M | $170.7M | ||
| Q1 25 | $285.9M | $109.0M | ||
| Q4 24 | $270.3M | $187.8M | ||
| Q3 24 | $329.7M | $62.5M | ||
| Q2 24 | $321.8M | $38.9M |
净利润ASBASND
| Q1 26 | $119.6M | — | ||
| Q4 25 | $137.1M | — | ||
| Q3 25 | $124.7M | $-65.9M | ||
| Q2 25 | $111.2M | $-42.0M | ||
| Q1 25 | $101.7M | $-102.2M | ||
| Q4 24 | $-161.6M | — | ||
| Q3 24 | $88.0M | $-107.1M | ||
| Q2 24 | $115.6M | $-118.1M |
毛利率ASBASND
| Q1 26 | — | — | ||
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 89.5% | ||
| Q2 25 | — | 80.1% | ||
| Q1 25 | — | 82.6% | ||
| Q4 24 | — | 91.9% | ||
| Q3 24 | — | 80.6% | ||
| Q2 24 | — | 68.2% |
营业利润率ASBASND
| Q1 26 | — | — | ||
| Q4 25 | 52.6% | — | ||
| Q3 25 | 50.5% | 5.1% | ||
| Q2 25 | 46.5% | -33.5% | ||
| Q1 25 | 42.3% | -103.2% | ||
| Q4 24 | -65.8% | — | ||
| Q3 24 | 32.8% | -167.3% | ||
| Q2 24 | 32.0% | -370.2% |
净利率ASBASND
| Q1 26 | 31.2% | — | ||
| Q4 25 | 44.2% | — | ||
| Q3 25 | 40.9% | -28.5% | ||
| Q2 25 | 37.1% | -24.6% | ||
| Q1 25 | 35.6% | -93.7% | ||
| Q4 24 | -59.8% | — | ||
| Q3 24 | 26.7% | -171.5% | ||
| Q2 24 | 35.9% | -303.9% |
每股收益（稀释后）ASBASND
| Q1 26 | $0.70 | — | ||
| Q4 25 | $0.80 | — | ||
| Q3 25 | $0.73 | — | ||
| Q2 25 | $0.65 | — | ||
| Q1 25 | $0.59 | — | ||
| Q4 24 | $-1.10 | — | ||
| Q3 24 | $0.56 | — | ||
| Q2 24 | $0.74 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $665.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $5.0B | $-175.8M |
| 总资产 | $45.6B | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASBASND
| Q1 26 | — | — | ||
| Q4 25 | — | $665.3M | ||
| Q3 25 | — | $582.2M | ||
| Q2 25 | — | $533.6M | ||
| Q1 25 | — | $559.4M | ||
| Q4 24 | — | $604.3M | ||
| Q3 24 | — | $675.6M | ||
| Q2 24 | — | $279.4M |
总债务ASBASND
| Q1 26 | — | — | ||
| Q4 25 | $1.0B | — | ||
| Q3 25 | $594.1M | — | ||
| Q2 25 | $593.5M | — | ||
| Q1 25 | $591.4M | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $844.3M | — | ||
| Q2 24 | $536.1M | — |
股东权益ASBASND
| Q1 26 | $5.0B | — | ||
| Q4 25 | $5.0B | $-175.8M | ||
| Q3 25 | $4.9B | $-188.0M | ||
| Q2 25 | $4.8B | $-202.6M | ||
| Q1 25 | $4.7B | $-205.0M | ||
| Q4 24 | $4.6B | $-114.2M | ||
| Q3 24 | $4.4B | $-105.1M | ||
| Q2 24 | $4.2B | $-346.8M |
总资产ASBASND
| Q1 26 | $45.6B | — | ||
| Q4 25 | $45.2B | $1.4B | ||
| Q3 25 | $44.5B | $1.2B | ||
| Q2 25 | $44.0B | $1.2B | ||
| Q1 25 | $43.3B | $1.1B | ||
| Q4 24 | $43.0B | $1.3B | ||
| Q3 24 | $42.2B | $1.2B | ||
| Q2 24 | $41.6B | $819.0M |
负债/权益比ASBASND
| Q1 26 | — | — | ||
| Q4 25 | 0.20× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.13× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.19× | — | ||
| Q2 24 | 0.13× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $58.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASBASND
| Q1 26 | — | — | ||
| Q4 25 | $218.1M | $58.2M | ||
| Q3 25 | $158.0M | — | ||
| Q2 25 | $141.5M | — | ||
| Q1 25 | $98.2M | $-15.5M | ||
| Q4 24 | $207.1M | $-330.7M | ||
| Q3 24 | $105.1M | — | ||
| Q2 24 | $113.5M | — |
现金转化率ASBASND
| Q1 26 | — | — | ||
| Q4 25 | 1.59× | — | ||
| Q3 25 | 1.27× | — | ||
| Q2 25 | 1.27× | — | ||
| Q1 25 | 0.97× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.19× | — | ||
| Q2 24 | 0.98× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASB
| Net Interest Income | $307.2M | 80% |
| Noninterest Income | $75.9M | 20% |
ASND
暂无分部数据
